HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹646 Cr | ₹432 Cr | ₹379 Cr | ₹410 Cr | ₹359 Cr |
What is the latest Total Non-Current Liabilities ratio of HIKAL ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹646 Cr |
Mar2022 | ₹432 Cr |
Mar2021 | ₹379 Cr |
Mar2020 | ₹410 Cr |
Mar2019 | ₹359 Cr |
How is Total Non-Current Liabilities of HIKAL Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹646 Cr | 49.67 | |
Mar2022 | ₹432 Cr | 13.96 | |
Mar2021 | ₹379 Cr | -7.60 | |
Mar2020 | ₹410 Cr | 14.12 | |
Mar2019 | ₹359 Cr | - |
Compare Total Non-Current Liabilities of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹3,667.6 Cr | -4.8% | 7.9% | 2.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | -4.8% |
7.9% |
2.4% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses